Navigation Links
Royalty Pharma Statement Regarding Elan Proposal

regarding returning cash to shareholders were also vague and reflected Elan's lack of focus on enhancing shareholder value. In general, Royalty Pharma believes that Elan expressed little concern for the views of Elan Shareholders during the Tysabri Conference Call, which included the following statements[12]:

  • "But to emphasize, the US$3.25 billion is a lot of money. There is a lot of assets out there. Our goal as we sit here today is that the majority of that capital over time should be put into businesses, again, in a balanced way. But again, some portion of it, given that we brought forward the value, will be returned to shareholders at the right time and post-close and as we sequence it against other transactions."
  • "As far as usage of this capital upon close, they include, but are not limited to, therapeutic opportunities across broad therapies.  We are basically agnostic to therapeutic focus."
  • "we are somewhat agnostic to different geographies . . . they all hold some appeal, depending on what part of the geography you're interested in . . .  we are not particularly interested in large markets, large indications of primary care, but large markets in smaller indications would be attractive and vice versa."
  • "And we still do like some very specific, unique science things."
  • "At the right time and in the right manner, we would intend to provide some portion of this capital back to shareholders over time."
  • "we are not going to satisfy all investors on every category . . . So anyway, everyone can vote with their feet."
  • The Elan Stock price fell by approximately 10 percent on the day of the Tysabri Conference Call.

    Elan's announcements since its receipt of Royalty Pharma's Proposal

    Royalty Pharma believes that Elan has changed its messages since receiving Royalty Pharma's Proposal, particularly with regard to shareholder returns.

    Having previously said that sharehol

    SOURCE RP Management, LLC
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

    Related biology technology :

    1. PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
    2. Cowen Healthcare Royalty Partners Raises $1 Billion
    3. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
    4. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
    5. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
    6. AVANIR Pharmaceuticals To participate in two conferences in March
    7. Favorable Scenario for Japan Pharma Industry in Coming Years, New Report Says
    8. Hyperion Wins NDA Approval for UCD Drug Developed With Support from PharmaDirections
    9. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
    10. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
    11. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
    Post Your Comments:
    (Date:7/22/2014)... 2014  United Therapeutics Corporation (NASDAQ: ... its second quarter 2014 financial results before market ... United Therapeutics will host a half-hour teleconference on ... Time.  The teleconference is accessible by dialing 1-877-351-5881, ... the teleconference will be available for one week ...
    (Date:7/22/2014)... PLAINS, New Jersey , 22. Juli 2014 ... für die Life-Sciences-Industrie, hat die Ernennung von Marcus ... bekanntgegeben. Herr Bergler hat die europäischen kommerziellen ... Lösungen unterstützt. Bevor er sich Qforma anschloss, war ... bei Cegedim Customer Information, als Vertriebsteam-Leiter Deutschland bei ...
    (Date:7/22/2014)... Sunnyvale, CA (PRWEB) July 22, 2014 ... begin on September 9th, 2014 and will comprise of ... and Application’ classes. The TechTrainings is a series of ... professionals, designed to help them reach the next step ... SAS class is taught by Jennifer Kang, Senior ...
    (Date:7/21/2014)... July 21, 2014 Lawrence ... Investment Board (WIB) and Las Positas College (LPC) ... technical education and hands-on training for veterans, officials ... Program at Las Positas is designed to ... for engineering technician careers, and establishes a pipeline ...
    Breaking Biology Technology:Qforma gibt Schaffung des neuen Postens als General Manager in Europa bekannt 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 3Engineering Program Established for Veterans 2Engineering Program Established for Veterans 3
    ... 2012  MiMedx Group, Inc. (OTCBB: MDXG), an integrated ... biomaterials and bioimplants processed from human amniotic membrane, ... agreement with Systagenix, whereby Systagenix will co-market EpiFix®. ... processed from amniotic tissue, EpiFix® offers a wide ...
    ... Centre (CNIO) routinely runs such tests on samples sent in ... first step towards a truly personalised medicine. And researchers are ... organism at a molecular scale: the genes that are being ... through the bloodstream; and the length of the telomeres capping ...
    ... WASHINGTON -- Advisor to President Barack Obama for the ... Holdren visited the Navy,s corporate laboratory, March 16, to ... Research (LASR) and tour the sprawling 130-acre Washington, D.C., ... the Navy, Marine Corps and our Nation in ever ...
    Cached Biology Technology:MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix® 2MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix® 3CNIO researchers take part in the most comprehensive personalized medicine study performed to date 2CNIO researchers take part in the most comprehensive personalized medicine study performed to date 3White House S&T advisor the Honorable Dr. John Holdren tours Naval Research Laboratory 2
    (Date:7/22/2014)... schoolyards that feature natural habitats and trees and not ... inattention, according to a University of Colorado Boulder study. ... settings also provide stress-reducing benefits for youth, according to ... Place. The study is one of the first ... student access to green settings and stress. , "Many ...
    (Date:7/22/2014)... meerkats which sees them prevent their daughters from breeding, ... study. , Research into the desert creatures which live ... helpers shows that the alpha female can flourish when ... shows how this way of life, also found in many ... its sinister side. , Dominant meerkats control breeding within ...
    (Date:7/22/2014)... the the genus of planthopper known as Conosimus, which ... recently discovered in the southern part of the Iberian ... of it appears in the open-access Journal of ... new species, Conosimus baenai , has been named ... to the taxonomy of Iberian Hemiptera. , Conosimus ...
    Breaking Biology News(10 mins):Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 2Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 3
    ... had knee replacement surgery -- finally able to walk and ... on pounds, but surprisingly that,s not the case, according to ... Lynn Snyder-Mackler in the Department of Physical Therapy in UD,s ... in the first few weeks after total knee arthroplasty (TKA), ...
    ... have shown multiple sclerosis (MS) patients are more often born ... is an environmental risk factor for the disease. A paper ... by Emmanuelle Waubant and Ellen Mowry, now suggests that this ... In many European populations, the HLA-DRB1*15 allele of this gene ...
    ... Journal of Clinical Endocrinology & Metabolism , shows that ... and reduced bone size in their grandsons. "This is ... has been demonstrated across two generations," says associate professor Mattias ... "This new risk factor may be significant for the diagnosis ...
    Cached Biology News:Most patients gain weight after getting a new knee, UD study finds 2Grandpa's broken hip may mean weaker bones for his grandsons 2
    Human plasmacytoid dendritic cells, BDCA-4+, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
    Umbilical cord blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
    Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
    Human peripheral blood CD56+ NK cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
    Biology Products: